Global Inactivated Vaccines Sales Market Report 2021

August 2016 | 107 pages | ID: G8188E4BB07EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Inactivated Vaccines

Revenue, means the sales value of Inactivated Vaccines

This report studies sales (consumption) of Inactivated Vaccines in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Astellas Pharma Inc
• CSL Limited
• Emergent BioSolutions, Inc
• GlaxoSmithKline
• Johnson & Johnson
• MedImmune, LLC
• Merck & Co
• Pfizer
• Sanofi Pasteur
• Serum Institute
• India Pvt. Ltd. (India)

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Inactivated Vaccines in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Pneumococcal
• Influenza
• HPV
• Hepatitis
• Rotavirus
• DTP
• Polio
• MMR

Split by applications, this report focuses on sales, market share and growth rate of Inactivated Vaccines in each application, can be divided into

• Pediatric
• Adult
• Application 3

Contents

Global Inactivated Vaccines Sales Market Report 2021

1 INACTIVATED VACCINES OVERVIEW

1.1 Product Overview and Scope of Inactivated Vaccines
1.2 Classification of Inactivated Vaccines
  1.2.1 Pneumococcal
  1.2.2 Influenza
  1.2.3 HPV
  1.2.4 Hepatitis
  1.2.5 Rotavirus
  1.2.6 DTP
  1.2.7 Polio
  1.2.8 MMR
1.3 Applications of Inactivated Vaccines
  1.3.1 Pediatric
  1.3.2 Adult
  1.3.3 Application
1.4 Inactivated Vaccines Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Inactivated Vaccines (2011-2021)
  1.5.1 Global Inactivated Vaccines Sales, Revenue and Price (2011-2021)
  1.5.2 Global Inactivated Vaccines Sales and Growth Rate (2011-2021)
  1.5.3 Global Inactivated Vaccines Revenue and Growth Rate (2011-2021)

2 GLOBAL INACTIVATED VACCINES COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Inactivated Vaccines Market Competition by Manufacturers
  2.1.1 Global Inactivated Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Global Inactivated Vaccines Revenue and Share by Manufacturers (2015 and 2016)
2.2 Global Inactivated Vaccines (Volume and Value) by Type
  2.2.1 Global Inactivated Vaccines Sales and Market Share by Type (2011-2021)
  2.2.2 Global Inactivated Vaccines Revenue and Market Share by Type (2011-2021)
2.3 Global Inactivated Vaccines (Volume and Value) by Regions
  2.3.1 Global Inactivated Vaccines Sales and Market Share by Regions (2011-2021)
  2.3.2 Global Inactivated Vaccines Revenue and Market Share by Regions (2011-2021)
2.4 Global Inactivated Vaccines (Volume) by Application

3 NORTH AMERICA INACTIVATED VACCINES (VOLUME, VALUE AND SALES PRICE

3.1 North America Inactivated Vaccines Sales and Value (2011-2021)
  3.1.1 North America Inactivated Vaccines Sales and Growth Rate (2011-2021)
  3.1.2 North America Inactivated Vaccines Revenue and Growth Rate (2011-2021)
  3.1.3 North America Inactivated Vaccines Sales Price Trend (2011-2021)
3.2 North America Inactivated Vaccines Sales and Market Share by Manufacturers
3.3 North America Inactivated Vaccines Sales and Market Share by Type
3.4 North America Inactivated Vaccines Sales and Market Share by Applications

4 CHINA INACTIVATED VACCINES (VOLUME, VALUE AND SALES PRICE

4.1 China Inactivated Vaccines Sales and Value (2011-2021)
  4.1.1 China Inactivated Vaccines Sales and Growth Rate (2011-2021)
  4.1.2 China Inactivated Vaccines Revenue and Growth Rate (2011-2021)
  4.1.3 China Inactivated Vaccines Sales Price Trend (2011-2021)
4.2 China Inactivated Vaccines Sales and Market Share by Manufacturers
4.3 China Inactivated Vaccines Sales and Market Share by Type
4.4 China Inactivated Vaccines Sales and Market Share by Applications

5 EUROPE INACTIVATED VACCINES (VOLUME, VALUE AND SALES PRICE

5.1 Europe Inactivated Vaccines Sales and Value (2011-2021)
  5.1.1 Europe Inactivated Vaccines Sales and Growth Rate (2011-2021)
  5.1.2 Europe Inactivated Vaccines Revenue and Growth Rate (2011-2021)
  5.1.3 Europe Inactivated Vaccines Sales Price Trend (2011-2021)
5.2 Europe Inactivated Vaccines Sales and Market Share by Manufacturers
5.3 Europe Inactivated Vaccines Sales and Market Share by Type
5.4 Europe Inactivated Vaccines Sales and Market Share by Applications

6 JAPAN INACTIVATED VACCINES (VOLUME, VALUE AND SALES PRICE

6.1 Japan Inactivated Vaccines Sales and Value (2011-2021)
  6.1.1 Japan Inactivated Vaccines Sales and Growth Rate (2011-2021)
  6.1.2 Japan Inactivated Vaccines Revenue and Growth Rate (2011-2021)
  6.1.3 Japan Inactivated Vaccines Sales Price Trend (2011-2021)
6.2 Japan Inactivated Vaccines Sales and Market Share by Manufacturers
6.3 Japan Inactivated Vaccines Sales and Market Share by Type
6.4 Japan Inactivated Vaccines Sales and Market Share by Applications

7 SOUTHEAST ASIA INACTIVATED VACCINES (VOLUME, VALUE AND SALES PRICE

7.1 Southeast Asia Inactivated Vaccines Sales and Value (2011-2021)
  7.1.1 Southeast Asia Inactivated Vaccines Sales and Growth Rate (2011-2021)
  7.1.2 Southeast Asia Inactivated Vaccines Revenue and Growth Rate (2011-2021)
  7.1.3 Southeast Asia Inactivated Vaccines Sales Price Trend (2011-2021)
7.2 Southeast Asia Inactivated Vaccines Sales and Market Share by Manufacturers
7.3 Southeast Asia Inactivated Vaccines Sales and Market Share by Type
7.4 Southeast Asia Inactivated Vaccines Sales and Market Share by Applications

8 INDIA INACTIVATED VACCINES (VOLUME, VALUE AND SALES PRICE

8.1 India Inactivated Vaccines Sales and Value (2011-2021)
  8.1.1 India Inactivated Vaccines Sales and Growth Rate (2011-2021)
  8.1.2 India Inactivated Vaccines Revenue and Growth Rate (2011-2021)
  8.1.3 India Inactivated Vaccines Sales Price Trend (2011-2021)
8.2 India Inactivated Vaccines Sales and Market Share by Manufacturers
8.3 India Inactivated Vaccines Sales and Market Share by Type
8.4 India Inactivated Vaccines Sales and Market Share by Applications

9 GLOBAL INACTIVATED VACCINES MANUFACTURERS ANALYSIS

9.1 Astellas Pharma Inc
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Inactivated Vaccines Product Type and Technology
    9.1.2.1 Pneumococcal
    9.1.2.2 Influenza
  9.1.3 Inactivated Vaccines Sales, Revenue, Price of Company One (2015 and 2016)
9.2 CSL Limited
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Inactivated Vaccines Product Type and Technology
    9.2.2.1 Pneumococcal
    9.2.2.2 Influenza
  9.2.3 Inactivated Vaccines Sales, Revenue, Price of Company One (2015 and 2016)
9.3 Emergent BioSolutions, Inc
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Inactivated Vaccines Product Type and Technology
    9.3.2.1 Pneumococcal
    9.3.2.2 Influenza
  9.3.3 Inactivated Vaccines Sales, Revenue, Price of Company One (2015 and 2016)
9.4 GlaxoSmithKline
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Inactivated Vaccines Product Type and Technology
    9.4.2.1 Pneumococcal
    9.4.2.2 Influenza
  9.4.3 Inactivated Vaccines Sales, Revenue, Price of Company One (2015 and 2016)
9.5 Johnson & Johnson
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Inactivated Vaccines Product Type and Technology
    9.5.2.1 Pneumococcal
    9.5.2.2 Influenza
  9.5.3 Inactivated Vaccines Sales, Revenue, Price of Company One (2015 and 2016)
9.6 MedImmune, LLC
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Inactivated Vaccines Product Type and Technology
    9.6.2.1 Pneumococcal
    9.6.2.2 Influenza
  9.6.3 Inactivated Vaccines Sales, Revenue, Price of Company One (2015 and 2016)
9.7 Merck & Co
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Inactivated Vaccines Product Type and Technology
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Inactivated Vaccines Sales, Revenue, Price of Company One (2015 and 2017)
9.8 Pfizer
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Inactivated Vaccines Product Type and Technology
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Inactivated Vaccines Sales, Revenue, Price of Company One (2015 and 2018)
9.9 Sanofi Pasteur
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Inactivated Vaccines Product Type and Technology
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Inactivated Vaccines Sales, Revenue, Price of Company One (2015 and 2019)
9.10 Serum Institute
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Inactivated Vaccines Product Type and Technology
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Inactivated Vaccines Sales, Revenue, Price of Company One (2015 and 2021)
9.11 India Pvt. Ltd. (India)

10 INACTIVATED VACCINES TECHNOLOGY AND DEVELOPMENT TREND

10.1 Inactivated Vaccines Technology Analysis
10.2 Inactivated Vaccines Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Inactivated Vaccines
Table Classification of Inactivated Vaccines
Figure Global Sales Market Share of Inactivated Vaccines by Type in 2015
Figure Pneumococcal Picture
Figure Influenza Picture
Figure HPV Picture
Figure Hepatitis Picture
Figure Rotavirus Picture
Figure DTP Picture
Figure Polio Picture
Figure MMR Picture
Table Applications of Inactivated Vaccines
Figure Global Sales Market Share of Inactivated Vaccines by Applications in 2015
Figure Pediatric Examples
Figure Adult Examples
Figure North America Inactivated Vaccines Revenue and Growth Rate (2011-2021)
Figure China Inactivated Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe Inactivated Vaccines Revenue and Growth Rate (2011-2021)
Figure Japan Inactivated Vaccines Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Inactivated Vaccines Revenue and Growth Rate (2011-2021)
Figure India Inactivated Vaccines Revenue and Growth Rate (2011-2021)
Table Global Inactivated Vaccines Sales, Revenue and Price (2011-2021)
Figure Global Inactivated Vaccines Sales and Growth Rate (2011-2021)
Figure Global Inactivated Vaccines Revenue and Growth Rate (2011-2021)
Table Global Inactivated Vaccines Sales of Key Manufacturers (2015 and 2016)
Table Global Inactivated Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Inactivated Vaccines Sales Share by Manufacturers
Figure 2016 Inactivated Vaccines Sales Share by Manufacturers
Table Global Inactivated Vaccines Revenue by Manufacturers (2015 and 2016)
Table Global Inactivated Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Inactivated Vaccines Revenue Share by Manufacturers
Table 2016 Global Inactivated Vaccines Revenue Share by Manufacturers
Table Global Inactivated Vaccines Sales and Market Share by Type (2011-2021)
Table Global Inactivated Vaccines Sales Share by Type (2011-2021)
Figure Sales Market Share of Inactivated Vaccines by Type (2011-2021)
Figure Global Inactivated Vaccines Sales Growth Rate by Type (2011-2021)
Table Global Inactivated Vaccines Revenue and Market Share by Type (2011-2021)
Table Global Inactivated Vaccines Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Inactivated Vaccines by Type (2011-2021)
Figure Global Inactivated Vaccines Revenue Growth Rate by Type (2011-2021)
Table Global Inactivated Vaccines Sales and Market Share by Regions (2011-2021)
Table Global Inactivated Vaccines Sales Share by Regions (2011-2021)
Figure Sales Market Share of Inactivated Vaccines by Regions (2011-2021)
Figure Global Inactivated Vaccines Sales Growth Rate by Regions (2011-2021)
Table Global Inactivated Vaccines Revenue and Market Share by Regions (2011-2021)
Table Global Inactivated Vaccines Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Inactivated Vaccines by Regions (2011-2021)
Figure Global Inactivated Vaccines Revenue Growth Rate by Regions (2011-2021)
Table Global Inactivated Vaccines Sales and Market Share by Application (2011-2021)
Table Global Inactivated Vaccines Sales Share by Application (2011-2021)
Figure Sales Market Share of Inactivated Vaccines by Application (2011-2021)
Figure Global Inactivated Vaccines Sales Growth Rate by Application (2011-2021)
Figure North America Inactivated Vaccines Sales and Growth Rate (2011-2021)
Figure North America Inactivated Vaccines Revenue and Growth Rate (2011-2021)
Figure North America Inactivated Vaccines Sales Price Trend (2011-2021)
Table North America Inactivated Vaccines Sales by Manufacturers (2015 and 2016)
Table North America Inactivated Vaccines Market Share by Manufacturers (2015 and 2016)
Table North America Inactivated Vaccines Sales by Type (2015 and 2016)
Table North America Inactivated Vaccines Market Share by Type (2015 and 2016)
Table North America Inactivated Vaccines Sales by Applications (2015 and 2016)
Table North America Inactivated Vaccines Market Share by Applications (2015 and 2016)
Figure Europe Inactivated Vaccines Sales and Growth Rate (2011-2021)
Figure Europe Inactivated Vaccines Revenue and Growth Rate (2011-2021)
Figure Europe Inactivated Vaccines Sales Price Trend (2011-2021)
Table Europe Inactivated Vaccines Sales by Manufacturers (2015 and 2016)
Table Europe Inactivated Vaccines Market Share by Manufacturers (2015 and 2016)
Table Europe Inactivated Vaccines Sales by Type (2015 and 2016)
Table Europe Inactivated Vaccines Market Share by Type (2015 and 2016)
Table Europe Inactivated Vaccines Sales by Applications (2015 and 2016)
Table Europe Inactivated Vaccines Market Share by Applications (2015 and 2016)
Figure China Inactivated Vaccines Sales and Growth Rate (2011-2021)
Figure China Inactivated Vaccines Revenue and Growth Rate (2011-2021)
Figure China Inactivated Vaccines Sales Price Trend (2011-2021)
Table China Inactivated Vaccines Sales by Manufacturers (2015 and 2016)
Table China Inactivated Vaccines Market Share by Manufacturers (2015 and 2016)
Table China Inactivated Vaccines Sales by Type (2015 and 2016)
Table China Inactivated Vaccines Market Share by Type (2015 and 2016)
Table China Inactivated Vaccines Sales by Applications (2015 and 2016)
Table China Inactivated Vaccines Market Share by Applications (2015 and 2016)
Figure Japan Inactivated Vaccines Sales and Growth Rate (2011-2021)
Figure Japan Inactivated Vaccines Revenue and Growth Rate (2011-2021)
Figure Japan Inactivated Vaccines Sales Price Trend (2011-2021)
Table Japan Inactivated Vaccines Sales by Manufacturers (2015 and 2016)
Table Japan Inactivated Vaccines Market Share by Manufacturers (2015 and 2016)
Table Japan Inactivated Vaccines Sales by Type (2015 and 2016)
Table Japan Inactivated Vaccines Market Share by Type (2015 and 2016)
Table Japan Inactivated Vaccines Sales by Applications (2015 and 2016)
Table Japan Inactivated Vaccines Market Share by Applications (2015 and 2016)
Figure India Inactivated Vaccines Sales and Growth Rate (2011-2021)
Figure India Inactivated Vaccines Revenue and Growth Rate (2011-2021)
Figure India Inactivated Vaccines Sales Price Trend (2011-2021)
Table India Inactivated Vaccines Sales by Manufacturers (2015 and 2016)
Table India Inactivated Vaccines Market Share by Manufacturers (2015 and 2016)
Table India Inactivated Vaccines Sales by Type (2015 and 2016)
Table India Inactivated Vaccines Market Share by Type (2015 and 2016)
Table India Inactivated Vaccines Sales by Applications (2015 and 2016)
Table India Inactivated Vaccines Market Share by Applications (2015 and 2016)
Figure Southeast Asia Inactivated Vaccines Sales and Growth Rate (2011-2021)
Figure Southeast Asia Inactivated Vaccines Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Inactivated Vaccines Sales Price Trend (2011-2021)
Table Southeast Asia Inactivated Vaccines Sales by Manufacturers (2015 and 2016)
Table Southeast Asia Inactivated Vaccines Market Share by Manufacturers (2015 and 2016)
Table Southeast Asia Inactivated Vaccines Sales by Type (2015 and 2016)
Table Southeast Asia Inactivated Vaccines Market Share by Type (2015 and 2016)
Table Southeast Asia Inactivated Vaccines Sales by Applications (2015 and 2016)
Table Southeast Asia Inactivated Vaccines Market Share by Applications (2015 and 2016)
Table Astellas Pharma Inc Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)
Table CSL Limited Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of CSL Limited (2015 and 2016)
Table Emergent BioSolutions, Inc Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table MedImmune, LLC Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)
Table Merck & Co Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Merck & Co (2015 and 2016)
Table Pfizer Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)
Table Sanofi Pasteur Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)
Table Serum Institute Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of Serum Institute (2015 and 2016)
Table India Pvt. Ltd. (India) Basic Information List
Table Inactivated Vaccines Sales, Revenue, Price of India Pvt. Ltd. (India) (2015 and 2016)